KPV inhibits NF-kB, a transcription factor that serves as the central regulator of multiple inflammatory gene programs
Inhibition by vasoactive intestinal peptide of glycoconjugate and lysozyme secretion by human airways in vitro
Avoid applying cold directly to injection sites within 30 minutes of injection
And of course, to really seriously consider the sourcing issue that we talked about earlier
What the research firmly supports: BPC-157's gut healing, vascular, and neuroprotective mechanisms (strong preclinical evidence) Thymosin Alpha-1's immune modulating and T-cell restorative effects (strong preclinical + clinical evidence in viral disease) TB-500's cardiovascular repair and angiogenic properties (strong preclinical, early human data) What the research does not yet confirm: Randomised controlled trial data specifically in long COVID populations Optimal dosing, sequencing, and duration specifically for PASC Long-term safety data for extended post-viral use This doesn't mean these peptides don't work for long COVID
Your body is struggling to heal from a persistent injury, and traditional treatments just arent working
